Literature DB >> 24296516

Thyroid cancer in 2013: Advances in our understanding of differentiated thyroid cancer.

Christoph Reiners1.   

Abstract

Studies published in 2013 have addressed the question of whether the rising incidence of differentiated thyroid cancer is actually the result of overdiagnosis. Advances have also been made in the treatment of differentiated thyroid cancer, including improvements in radioiodine therapy.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24296516     DOI： 10.1038/nrendo.2013.247

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  10 in total

1.  Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006.

Authors:  Benoit Guay; Stephanie Johnson-Obaseki; James Ted McDonald; Chris Connell; Martin Corsten
Journal:  Thyroid       Date:  2013-11-14       Impact factor: 6.568

Review 2.  Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008.

Authors:  Nan Li; Xianglin L Du; Lorraine R Reitzel; Li Xu; Erich M Sturgis
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

3.  The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.

Authors:  Christopher Kim; Xiaofeng Bi; Dongsheng Pan; Yingtai Chen; Tobias Carling; Shuangge Ma; Robert Udelsman; Yawei Zhang
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

4.  Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.

Authors:  M M Sabra; J M Dominguez; R K Grewal; S M Larson; R A Ghossein; R M Tuttle; J A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

5.  Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.

Authors:  Christoph Reiners; Johannes Biko; Heribert Haenscheid; Helge Hebestreit; Stalina Kirinjuk; Oleg Baranowski; Robert J Marlowe; Ewgeni Demidchik; Valentina Drozd; Yuri Demidchik
Journal:  J Clin Endocrinol Metab       Date:  2013-04-24       Impact factor: 5.958

6.  Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland.

Authors:  K O Franssila; H R Harach
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

7.  Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Authors:  Alan L Ho; Ravinder K Grewal; Rebecca Leboeuf; Eric J Sherman; David G Pfister; Desiree Deandreis; Keith S Pentlow; Pat B Zanzonico; Sofia Haque; Somali Gavane; Ronald A Ghossein; Julio C Ricarte-Filho; José M Domínguez; Ronglai Shen; R Michael Tuttle; Steve M Larson; James A Fagin
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

8.  The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds.

Authors:  Robert Udelsman; Yawei Zhang
Journal:  Thyroid       Date:  2013-10-29       Impact factor: 6.568

9.  The increasing incidence of thyroid cancer: the influence of access to care.

Authors:  Luc G T Morris; Andrew G Sikora; Tor D Tosteson; Louise Davies
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

10.  The incidence of thyroid cancer is affected by the characteristics of a healthcare system.

Authors:  Tae-Jin Lee; Sun Kim; Hong-Jun Cho; Jae-Ho Lee
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153
  10 in total
  5 in total

1.  Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role?

Authors:  Valentina M Drozd; Vladimir A Saenko; Alina V Brenner; Vladimir Drozdovitch; Vasilii I Pashkevich; Anatoliy V Kudelsky; Yuri E Demidchik; Igor Branovan; Nikolay Shiglik; Tatiana I Rogounovitch; Shunichi Yamashita; Johannes Biko; Christoph Reiners
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

2.  Molecular pathways associated with aggressiveness of papillary thyroid cancer.

Authors:  Salvatore Benvenga; Christian A Koch
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

Review 3.  How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.

Authors:  Carole Spencer; Jonathan LoPresti; Shireen Fatemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

4.  AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.

Authors:  Caterina Mian; Filippo Ceccato; Susi Barollo; Sara Watutantrige-Fernando; Nora Albiger; Daniela Regazzo; Paola de Lazzari; Gianmaria Pennelli; Sandra Rotondi; Davide Nacamulli; Maria Rosa Pelizzo; Marie-Lise Jaffrain-Rea; Franco Grimaldi; Gianluca Occhi; Carla Scaroni
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

5.  GPX7 promotes the growth of human papillary thyroid carcinoma via enhancement of cell proliferation and inhibition of cell apoptosis.

Authors:  Li-Dan Liu; Yi-Ni Zhang; Li-Fen Wang
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.